• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Recurrent Respiratory Papillomatosis: Much Has Been Done, but a Long Road Lies Ahead

by Nancy M. Bauman, MD • October 1, 2006

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Early in the course of investigation are two topical agents that may eventually be useful for managing laryngeal papillomata. Ionic contraviral therapy (ICVT, Henderson Morley, UK) is an antiviral agent with excellent efficacy in treating plantar warts. It reportedly alters the host cell to create a hostile environment rather than affecting the virus itself. Carrageenan is an extract of red algae and is used as a thickener in many foods, cosmetic products, and even vaginal gels. This agent inhibits binding of HPV to the target cells and may prove useful as a lubricant gel.

You Might Also Like

  • Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
  • Promise for Recurrent Respiratory Papillomatosis: Pediatric otolaryngologists have high hopes for the HPV vaccine
  • Recurrent Respiratory Papillomatosis: Researchers Advancing Toward Prevention
  • Vaccination and Medical Advancements Helping to Decrease Recurrent Respiratory Papillomatosis Incidence
Explore This Issue
October 2006

RRP Resources

No editorial comment would be complete without commenting on the accomplishments of the RRP Task Force. Headed by Craig Derkay, MD (Eastern Virginia Medical School), the RRP Task Force is credited for widespread dissemination of knowledge regarding RRP. Initiated in 1994 following a survey of members of ASPO, the ABEA, and the AAO-HNS regarding the treatment of RRP, the task force has made great strides in establishing a nationwide registry for juvenile onset RRP, in analyzing the demographics of patients with RRP, in assessing various treatment modalities and in fostering the continued research of treatment. The annual AAO-HNSF instructional course offered by Craig Derkay and Brian Wiatrak, MD (University of Alabama) is a must for physicians treating patients with RRP who wish to know the current and future trends in disease management.

Patients with RRP should be made aware of the RRP Foundation directed by Bill Stern (www.rrpf.org ). This nonprofit organization, established in 1992, serves as an outstanding information resource for patients, families, and practitioners, and promotes public awareness of this devastating disease.

In summary, the future looks promising for the management of RRP. Although a cure is not imminent, we may be on the cusp of preventing this disease with vaccine therapy. We can all hope for the day when discussions of the management of laryngeal papillomas become of historic interest only.

©2006 The Triological Society

Pages: 1 2 3 | Single Page

Filed Under: Departments, Head and Neck, Medical Education, Pediatric, Practice Focus Tagged With: pediatrics, prevention, research, respiratory papillomatosis, treatment, vaccineIssue: October 2006

You Might Also Like:

  • Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
  • Promise for Recurrent Respiratory Papillomatosis: Pediatric otolaryngologists have high hopes for the HPV vaccine
  • Recurrent Respiratory Papillomatosis: Researchers Advancing Toward Prevention
  • Vaccination and Medical Advancements Helping to Decrease Recurrent Respiratory Papillomatosis Incidence

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you invented or patented something that betters the field of otolaryngology?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists as Entrepreneurs: Transforming Patient Care And Practice

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Continued Discussion And Engagement Are Essential To How Otolaryngologists Are Championing DEI Initiatives In Medicine

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Leaky Pipes—Time to Focus on Our Foundations
    • You Are Among Friends: The Value Of Being In A Group
    • How To: Full Endoscopic Procedures of Total Parotidectomy
    • How To: Does Intralesional Steroid Injection Effectively Mitigate Vocal Fold Scarring in a Rabbit Model?
    • What Is the Optimal Anticoagulation in HGNS Surgery in Patients with High-Risk Cardiac Comorbidities?

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939